Dorman Products (NASDAQ:DORM) reported Q2 EPS of $1.29, $0.02 worse than the analyst estimate of $1.31. Revenue for the quarter came in at $417.4 million versus the consensus estimate of $399.7 million.
Share repurchase program increased to $600 million and extended through December 31, 2024.
GUIDANCE:
Dorman Products sees FY2022 EPS of $5.00-$5.20, versus the consensus of $5.53.